Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Children with Sepsis
NCT06556511Completed
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sepsis comparing Zinc Group with Placebo Group (2 arms). Primary endpoint: Effectiveness of standard therapy with zinc at 10 days. Started Feb 2024; status: completed.
02
Drugs
zinc
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06556511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06556511.